MXPA00007165A - Polinucleotidos y polipeptidos de meth1 y meth2. - Google Patents

Polinucleotidos y polipeptidos de meth1 y meth2.

Info

Publication number
MXPA00007165A
MXPA00007165A MXPA00007165A MXPA00007165A MXPA00007165A MX PA00007165 A MXPA00007165 A MX PA00007165A MX PA00007165 A MXPA00007165 A MX PA00007165A MX PA00007165 A MXPA00007165 A MX PA00007165A MX PA00007165 A MXPA00007165 A MX PA00007165A
Authority
MX
Mexico
Prior art keywords
amino acids
polypeptide
meth2
meth1
seq
Prior art date
Application number
MXPA00007165A
Other languages
English (en)
Spanish (es)
Inventor
A Hastings Gregg
Original Assignee
Beth Israel Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beth Israel Hospital filed Critical Beth Israel Hospital
Publication of MXPA00007165A publication Critical patent/MXPA00007165A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/515—Angiogenesic factors; Angiogenin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Vascular Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
MXPA00007165A 1998-01-23 1999-01-22 Polinucleotidos y polipeptidos de meth1 y meth2. MXPA00007165A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7229898P 1998-01-23 1998-01-23
US9853998P 1998-08-28 1998-08-28
PCT/US1999/001313 WO1999037660A1 (en) 1998-01-23 1999-01-22 Meth1 and meth2 polynucleotides and polypeptides

Publications (1)

Publication Number Publication Date
MXPA00007165A true MXPA00007165A (es) 2002-06-21

Family

ID=26753215

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA00007165A MXPA00007165A (es) 1998-01-23 1999-01-22 Polinucleotidos y polipeptidos de meth1 y meth2.

Country Status (9)

Country Link
EP (1) EP1049708A4 (https=)
JP (1) JP2002501077A (https=)
KR (1) KR20010086224A (https=)
CN (1) CN1292796A (https=)
AU (1) AU766787B2 (https=)
CA (1) CA2319109A1 (https=)
MX (1) MXPA00007165A (https=)
NZ (1) NZ505855A (https=)
WO (1) WO1999037660A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001512681A (ja) 1997-08-06 2001-08-28 ミレニウム バイオセラピューティクス インク． Ｔａｎｇｏ−７１、Ｔａｎｇｏ−７３、Ｔａｎｇｏ−７４、Ｔａｎｇｏ−７６およびＴａｎｇｏ−８３核酸分子およびポリペプチド
DE19806581A1 (de) * 1998-02-17 1999-10-21 Forschungszentrum Juelich Gmbh Sequenzen eines Ih-Ionenkanals und deren Verwendung
US6649377B1 (en) * 1999-05-10 2003-11-18 Syntex (U.S.A.) Llc Human aggrecanase and nucleic acid compositions encoding the same
CA2371434A1 (en) * 1999-06-09 2000-12-14 Genentech, Inc. Compositions and methods for the treatment of tumor
US6395889B1 (en) * 1999-09-09 2002-05-28 Millennium Pharmaceuticals, Inc. Nucleic acid molecules encoding human protease homologs
EP1892250A3 (en) * 2000-01-31 2008-09-17 Munin Corporation CYR61 compositions and methods
CA2388673A1 (en) * 2000-03-31 2001-10-11 Bayer Corporation Protein having activity as an angiogenesis modulator
JP2002330761A (ja) * 2000-04-26 2002-11-19 Pfizer Prod Inc Ａｄａｍｔｓポリペプチド、それをコードする核酸、及びその使用
JP2004524003A (ja) * 2000-06-29 2004-08-12 コリクサ コーポレイション 肺癌の治療および診断のための組成物および方法
CA2442993C (en) 2001-04-10 2011-10-11 Agensys, Inc. Nucleic acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer
WO2003050268A2 (en) 2001-12-12 2003-06-19 Aventis Pasteur Limited Enhancement of the immune response using cd36-binding domain
ATE441713T1 (de) * 2002-09-27 2009-09-15 Dainippon Sumitomo Pharma Co Tumorantigenprotein und dessen verwendung
WO2010047310A1 (ja) 2008-10-20 2010-04-29 大日本住友製薬株式会社 腫瘍抗原ペプチド及びその利用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998055643A1 (en) * 1997-06-03 1998-12-10 Kureha Chemical Industry Co., Ltd. Human adamts-1 protein, gene coding for the same, pharmaceutical composition, and method for immunologically assaying human adamts-1 protein
JP2001512681A (ja) * 1997-08-06 2001-08-28 ミレニウム バイオセラピューティクス インク． Ｔａｎｇｏ−７１、Ｔａｎｇｏ−７３、Ｔａｎｇｏ−７４、Ｔａｎｇｏ−７６およびＴａｎｇｏ−８３核酸分子およびポリペプチド

Also Published As

Publication number Publication date
CA2319109A1 (en) 1999-07-29
WO1999037660A1 (en) 1999-07-29
JP2002501077A (ja) 2002-01-15
AU766787B2 (en) 2003-10-23
NZ505855A (en) 2005-01-28
EP1049708A1 (en) 2000-11-08
KR20010086224A (ko) 2001-09-10
EP1049708A4 (en) 2002-09-04
CN1292796A (zh) 2001-04-25
WO1999037660A9 (en) 1999-10-14
AU2464199A (en) 1999-08-09

Similar Documents

Publication Publication Date Title
TW538049B (en) A novel human osteoclastogenesis inhibitory factor and a process for preparing the same
AU2023214237A1 (en) Modified polynucleotides for the production of biologics and proteins associated with human disease
US6262333B1 (en) Human genes and gene expression products
AU2021202758A1 (en) Terminally modified RNA
KR20210049859A (ko) 게놈을 조절하는 방법 및 조성물
EP1039801A1 (en) 207 human secreted proteins
CZ20023567A3 (cs) Sloučeniny a způsoby pro terapii a diagnostiku karcinomu plic
WO1998039448A9 (en) 186 human secreted proteins
AU766787B2 (en) Meth1 and meth2 polynucleotides and polypeptides
JPH10510986A (ja) メタロプロテイナーゼ−４のヒト組織インヒビター
WO1998056804A1 (en) 86 human secreted proteins
WO1999007738A2 (en) Human orphan receptor ntr-1
JPH10502534A (ja) 結合組織増殖因子−２
US20040002449A1 (en) METH1 and METH2 polynucleotides and polypeptides
CA2338386A1 (en) Proteases and associated proteins
US20030092900A1 (en) Meth1 and Meth2 polynucleotides and polypeptides
US6274339B1 (en) Methods and compositions for the diagnosis and treatment of body weight disorders, including obesity
JP2003525566A (ja) １２５個のヒト分泌タンパク質
JP2003156489A (ja) 痛みに関連する分子の同定及び使用
US6713277B1 (en) Methods and composition for the diagnosis and treatment of body weight disorders, including obesity
EP1002132A1 (en) 90 human secreted proteins
JP2003521865A (ja) １４８個のヒト分泌タンパク質
CN1469926A (zh) 治疗和诊断肺癌的组合物和方法
JP2001507227A (ja) 小脳および胚に特異的なタンパク質
US20030144492A1 (en) 101 human secreted proteins